Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads ⊖
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli Lilly
since
auto-detected in 173 stories
47 hours ago
Denmark's Novo Nordisk said on Tuesday that it had sued Lilly, arguing consumers were being misled about how the companies' products compare.
4 days ago
Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads ⊖
found
a story from The Guardian ⚠️ › International
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective
Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “…
Jim Cramer says he's standing by Eli Lilly after rival's GLP-1 lawsuit. Here's why ⊖
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Ozempic-maker sues rival, accusing it of false advertising ○
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising ⊖
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fight ○
Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy
26 days ago
Medicare will start covering obesity drugs for the first time. Here's what patients should know ⊕
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
27 days ago
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet ⊖
Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
29 days ago
Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more ○
Here are the companies making headlines in midday trading.
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage ⊖
New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.